Nature

How CRISPR patent issues block Indian farmers from accessing biotech benefits


Increasingly, agricultural scientists in Asia and Africa are using the gene-editing tool CRISPR to develop disease-resistant, high-yield crop varieties. Many, especially those in government research laboratories, are underestimating the importance of the patent and licensing rules that surround tools such as CRISPR.

  • Access the most recent journalism from Nature’s award-winning team
  • Explore the latest features & opinion covering groundbreaking research

or

Competing Interests

The author declares no competing interests.



Source link

WyomingDigitalNews